+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lung Cancer Surgery Market - Global Forecast 2026-2032- Product Image
Lung Cancer Surgery Market - Global Forecast 2026-2032- Product Image
New

Lung Cancer Surgery Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674625
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The lung cancer surgery market is undergoing significant transformation, shaped by clinical advancements, technology integration, and shifting policy environments. Decision-makers in thoracic oncology must translate these dynamics into practical strategies to drive adoption, streamline workflows, and maintain competitive advantage.

Market Snapshot

The Lung Cancer Surgery Market grew from USD 6.94 billion in 2025 to USD 7.60 billion in 2026. It is expected to continue growing at a CAGR of 10.82%, reaching USD 14.25 billion by 2032. Robust growth is underpinned by broad adoption of minimally invasive techniques, expanding surgical infrastructure, and evolving payer landscapes shaping both global and regional demand.

Scope & Segmentation

  • Procedural Approaches: Emphasis on minimally invasive methods, such as robotic-assisted thoracic surgery and video-assisted thoracoscopic surgery; open procedures remain relevant in selected clinical scenarios.
  • Device Categories: Includes access devices, trocars, endoscopes, advanced visualization systems, energy devices (bipolar, electrosurgical, ultrasonic), and stapling technologies.
  • Cancer Subtypes: Non-small cell presentations like adenocarcinoma, large cell carcinoma, and squamous cell carcinoma drive a diverse range of surgical indications; small cell subtypes typically integrate systemic therapies.
  • Care Settings: Hospitals with integrated perioperative services pursue complex cases; ambulatory surgical centers prioritize streamlined disposables and efficiency for high turnover procedures.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific each require tailored approaches based on regulatory, procurement, and clinical practice landscapes.
  • Innovative Technologies: Integration of interoperable systems, enhanced imaging, energy modalities, and digital solutions for intraoperative decision support and post-operative outcomes tracking.

Lung Cancer Surgery Market: Key Takeaways

  • Minimally invasive techniques increasingly replace open surgery in leading centers, accelerating patient recovery and supporting higher case throughput.
  • Device manufacturers advance innovation through integration of enhanced energy modalities, next-generation stapling, and visualization platforms, with a focus on modular design and workflow efficiency.
  • Healthcare providers adapt care pathways by optimizing perioperative protocols, expanding use of ambulatory settings, and implementing standardized recovery programs to maximize resource utilization.
  • Strategic partnerships, acquisitions, and targeted R&D drive competitive positioning, with outcome-based commercialization gaining traction among both platform incumbents and specialist innovators.
  • Provider and supplier strategies increasingly prioritize real-world usability, scalable clinician training, and robust post-market evidence to facilitate adoption and payer alignment.
  • Tariff policies, especially post-2025 regulations, are reshaping supply chains, leading to local manufacturing moves, supplier diversification, and emphasis on regulatory harmonization.

Tariff Impact

The introduction of 2025 tariff measures, particularly in the United States, altered global procurement, manufacturing, and supply chain strategies for lung cancer surgical devices. Increased landed costs motivated health systems to shift supplier relationships, accelerate nearshoring, and pursue local manufacturing where feasible. Device firms responded by adapting sourcing models, restructuring inventory strategies, and enhancing collaboration between R&D and procurement teams to deliver regionally competitive, cost-effective device configurations. Clinicians handled operational disruptions with short-term inventory adjustments and rapid substitution, while regulatory teams intensified trade and compliance monitoring.

Methodology & Data Sources

This report synthesizes in-depth clinician interviews, structured regulatory review, and triangulation with clinical literature and procurement documents. Additional validation was achieved through expert consultations and systematic outcome study analysis to ensure recommendations align with current evidence and evolving policy. Segmentation frameworks structure actionable insights by modality, device category, cancer subtype, and care setting.

Why This Report Matters

  • Enables strategic planning by connecting clinical developments, technology shifts, and policy changes with procurement and investment priorities.
  • Supports operational decision-making with granular, segment-focused insights, guiding manufacturers and providers as they adapt supply chain, training, and adoption models.
  • Equips market leaders to anticipate region-specific regulatory and reimbursement challenges, ensuring agile positioning in a dynamic healthcare environment.

Conclusion

The lung cancer surgery market is advancing through innovation in technology, procedural design, and supply chain resilience. Effective strategic alignment between clinical, regulatory, and commercial priorities is essential for organizations seeking sustainable leadership and measurable outcomes within this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Lung Cancer Surgery Market, by Approach
8.1. Minimally Invasive
8.1.1. Robotic Assisted Thoracic Surgery (Rats)
8.1.2. Video Assisted Thoracoscopic Surgery (Vats)
8.1.2.1. Multiportal
8.1.2.2. Uniportal
8.2. Open Surgery
9. Lung Cancer Surgery Market, by Product Type
9.1. Access Devices And Trocars
9.2. Endoscopes And Visualization Systems
9.3. Energy Devices
9.3.1. Advanced Bipolar Devices
9.3.2. Electrosurgical Devices
9.3.3. Ultrasonic Energy Devices
9.4. Stapling Devices
9.4.1. Manual Staplers
9.4.2. Powered Staplers
10. Lung Cancer Surgery Market, by Cancer Type
10.1. Non Small Cell Lung Cancer
10.1.1. Adenocarcinoma
10.1.2. Large Cell Carcinoma
10.1.3. Squamous Cell Carcinoma
10.2. Small Cell Lung Cancer
11. Lung Cancer Surgery Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
12. Lung Cancer Surgery Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Lung Cancer Surgery Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Lung Cancer Surgery Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Lung Cancer Surgery Market
16. China Lung Cancer Surgery Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Ambu A/S
17.6. B. Braun SE
17.7. Becton Dickinson and Company
17.8. Boston Scientific Corporation
17.9. Fujifilm Holdings Corporation
17.10. GE HealthCare Technologies Inc.
17.11. Intuitive Surgical, Inc.
17.12. Johnson & Johnson
17.13. KARL STORZ SE & Co. KG
17.14. Medtronic plc
17.15. Olympus Corporation
17.16. Siemens Healthineers AG
17.17. Smith & Nephew plc
17.18. Stryker Corporation
17.19. Teleflex Incorporated
17.20. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA LUNG CANCER SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MULTIPORTAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MULTIPORTAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MULTIPORTAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY UNIPORTAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY UNIPORTAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY UNIPORTAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ACCESS DEVICES AND TROCARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ACCESS DEVICES AND TROCARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ACCESS DEVICES AND TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADVANCED BIPOLAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADVANCED BIPOLAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADVANCED BIPOLAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ULTRASONIC ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ULTRASONIC ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ULTRASONIC ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MANUAL STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MANUAL STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED STAPLERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED STAPLERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADENOCARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADENOCARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LARGE CELL CARCINOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LARGE CELL CARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LARGE CELL CARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SMALL CELL LUNG CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SMALL CELL LUNG CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SMALL CELL LUNG CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 82. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 120. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 121. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 122. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 124. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 125. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 127. EUROPE LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 140. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 141. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 142. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 144. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 145. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 147. AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 161. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 163. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 165. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 166. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 168. ASEAN LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. GCC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GCC LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 171. GCC LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 172. GCC LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 173. GCC LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. GCC LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 175. GCC LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 176. GCC LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 178. GCC LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. BRICS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 191. BRICS LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 192. BRICS LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 193. BRICS LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. BRICS LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 195. BRICS LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 196. BRICS LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 197. BRICS LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 198. BRICS LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. G7 LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. G7 LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 201. G7 LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 202. G7 LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 203. G7 LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 205. G7 LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 206. G7 LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 207. G7 LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 208. G7 LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. NATO LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. NATO LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 211. NATO LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 212. NATO LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 213. NATO LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. NATO LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 215. NATO LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 216. NATO LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 217. NATO LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 218. NATO LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. CHINA LUNG CANCER SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 231. CHINA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
TABLE 232. CHINA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
TABLE 233. CHINA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2032 (USD MILLION)
TABLE 234. CHINA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. CHINA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2032 (USD MILLION)
TABLE 236. CHINA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2032 (USD MILLION)
TABLE 237. CHINA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2032 (USD MILLION)
TABLE 238. CHINA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2032 (USD MILLION)
TABLE 239. CHINA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Lung Cancer Surgery market report include:
  • Ambu A/S
  • B. Braun SE
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.6 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.25 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Lung Cancer Surgery Market Report 2025 - Product Image

Lung Cancer Surgery Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Lung Cancer Surgery Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Lung Cancer Surgery Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Lung Cancer Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Lung Cancer Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Lung Cancer Surgery - Global Strategic Business Report - Product Image

Lung Cancer Surgery - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Minimally Invasive Thoracic Surgery Market - Global Forecast 2026-2032 - Product Image

Minimally Invasive Thoracic Surgery Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From

About the Lung Cancer Surgery Market

Lung cancer surgery is a medical procedure used to treat lung cancer. It is often used in combination with other treatments such as chemotherapy and radiation therapy. The goal of surgery is to remove the cancerous tissue and any surrounding tissue that may be affected. Surgery is usually the first line of treatment for early-stage lung cancer, and may be used in more advanced stages as well. The lung cancer surgery market is a subset of the larger lung cancer drugs market. It is composed of medical devices, surgical instruments, and other products used in the surgical treatment of lung cancer. Companies in this market include medical device manufacturers, surgical instrument suppliers, and other companies that provide products and services related to lung cancer surgery. Some companies in the lung cancer surgery market include Medtronic, Stryker, Johnson & Johnson, Becton Dickinson, and Smith & Nephew. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.